Medindia

X

UPDATE 1-Vivus Receives Permission from FDA to Sell Diet Pill Through Retail Pharmacies

by Savitha C Muppala on  April 19, 2013 at 1:36 AM Drug News   - G J E 4
U.S. health regulators' have approved the sale of Vivus Inc's diet pill, Qsymia, through retail pharmacies. This is a significant development for the company and is a shot in the arm for the direct-to-consumer campaign scheduled to be introduced later this year.
 UPDATE 1-Vivus Receives Permission from FDA to Sell Diet Pill Through Retail Pharmacies
UPDATE 1-Vivus Receives Permission from FDA to Sell Diet Pill Through Retail Pharmacies
Advertisement

This announcement gave a good boost to Vivus shares, which rose as much as 6 percent to $12.35 on the Nasdaq.

Advertisement
The company is working towards increasing the commercialization support for the diet pill.

The U.S. Food and Drug Administration accepted Vivus's proposal to allow Qsymia's sale through certified retail pharmacies so that drug will be available within 90 days.

The company is also in talks with insurers and pharmacy benefit managers to improve Qsymia's reimbursement.



Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All